Literature DB >> 24077109

Endothelin receptor signaling: new insight into its regulatory mechanisms.

Takahiro Horinouchi1, Koji Terada, Tsunehito Higashi, Soichi Miwa.   

Abstract

The endothelin (ET) system consists of two G protein coupled-receptors (GPCRs), ET type A receptor (ETAR) and ET type B receptor (ETBR), and three endogenous ligands, ET-1, ET-2, and ET-3. Stimulation of ETRs with ET-1 induces an increase in intracellular Ca(2+) concentration that is involved in a diverse array of physiological and pathophysiological processes, including vasoconstriction, and cell proliferation. Store-operated Ca(2+) entry and receptor-operated Ca(2+) entry triggered by activation of ETRs are regulated or modulated by endoplasmic reticulum Ca(2+) sensor (stromal interaction molecule 1) and voltage-independent cation channels (transient receptor potential canonical channels and Orai1). The ET-1-induced Ca(2+) mobilization results from activation of heterotrimeric G proteins by ETRs. In contrast, GPCR biology including modulation of receptor function and trafficking is regulated by a variety of GPCR interacting proteins (GIPs) that generally interact with the C-terminal domain of GPCRs. The ETR signaling is also regulated by GIPs such as Jun activation domain-binding protein 1. This review focuses on the regulatory mechanisms of the ETR signaling with special attention to the components involved in Ca(2+) signaling and to GIPs in the signal transduction, modification, and degradation of ETRs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24077109     DOI: 10.1254/jphs.13r02cr

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  31 in total

1.  Mechanisms of Atherosclerosis: New Insights and Novel Therapeutic Approaches.

Authors:  John P Cooke
Journal:  Methodist Debakey Cardiovasc J       Date:  2015 Jul-Sep

2.  Rendomab B4, a monoclonal antibody that discriminates the human endothelin B receptor of melanoma cells and inhibits their migration.

Authors:  Aurélie Borrull; Bertrand Allard; Anne Wijkhuisen; Amaury Herbet; Patricia Lamourette; Wided Birouk; Denis Leiber; Zahra Tanfin; Frédéric Ducancel; Didier Boquet; Jean-Yves Couraud; Philippe Robin
Journal:  MAbs       Date:  2016-07-08       Impact factor: 5.857

3.  Endothelin-A receptor antagonists in prostate cancer treatment-a meta-analysis.

Authors:  Longwei Qiao; Yuting Liang; Na Li; Xiaoxia Hu; Dongwei Luo; Junxia Gu; Yaojuan Lu; Qiping Zheng
Journal:  Int J Clin Exp Med       Date:  2015-03-15

Review 4.  Inhibition of ENaC by endothelin-1.

Authors:  Andrey Sorokin; Alexander Staruschenko
Journal:  Vitam Horm       Date:  2015-03-06       Impact factor: 3.421

5.  Agonist-promoted ubiquitination differentially regulates receptor trafficking of endothelin type A and type B receptors.

Authors:  Koji Terada; Takahiro Horinouchi; Yoichiro Fujioka; Tsunehito Higashi; Prabha Nepal; Mika Horiguchi; Sarita Karki; Chizuru Hatate; Akimasa Hoshi; Takuya Harada; Yosuke Mai; Yusuke Ohba; Soichi Miwa
Journal:  J Biol Chem       Date:  2014-11-07       Impact factor: 5.157

6.  Increased cerebrovascular sensitivity to endothelin-1 in a rat model of obstructive sleep apnea: a role for endothelin receptor B.

Authors:  David J Durgan; Randy F Crossland; Eric E Lloyd; Sharon C Phillips; Robert M Bryan
Journal:  J Cereb Blood Flow Metab       Date:  2014-11-26       Impact factor: 6.200

Review 7.  Antibodies against Angiotensin II Type 1 and Endothelin A Receptors: Relevance and pathogenicity.

Authors:  Mary Carmelle Philogene; Tory Johnson; Arthur Jason Vaught; Sammy Zakaria; Neal Fedarko
Journal:  Hum Immunol       Date:  2019-04-19       Impact factor: 2.850

8.  Endothelin-1 suppresses insulin-stimulated Akt phosphorylation and glucose uptake via GPCR kinase 2 in skeletal muscle cells.

Authors:  Takahiro Horinouchi; Akimasa Hoshi; Takuya Harada; Tsunaki Higa; Sarita Karki; Koji Terada; Tsunehito Higashi; Yosuke Mai; Prabha Nepal; Yuichi Mazaki; Soichi Miwa
Journal:  Br J Pharmacol       Date:  2016-02-15       Impact factor: 8.739

9.  Endotoxemia Induces IκBβ/NF-κB-Dependent Endothelin-1 Expression in Hepatic Macrophages.

Authors:  Sarah McKenna; Megan Gossling; Alejandro Bugarini; Elizabeth Hill; Aimee L Anderson; Raymond C Rancourt; Natarajan Balasubramaniyan; Karim C El Kasmi; Clyde J Wright
Journal:  J Immunol       Date:  2015-09-04       Impact factor: 5.422

10.  Endothelin receptor antagonists for pulmonary arterial hypertension.

Authors:  Chao Liu; Junmin Chen; Yanqiu Gao; Bao Deng; Kunshen Liu
Journal:  Cochrane Database Syst Rev       Date:  2021-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.